Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Sirtris' Series B Gets $27M For Class III HDAC Research

March 8, 2005

By Jennifer Boggs

Sirtris' Series B Gets $27M For Class III HDAC Research

March 8, 2005

By Jennifer Boggs

Neurochem Raising $61M For Alzhemed's Phase III Studies

March 7, 2005

By Jennifer Boggs

Neurochem Raising $61M For Alzhemed's Phase III Studies

March 7, 2005

By Jennifer Boggs

Allos Secures $50M Investment For Efaproxyn Phase III Program

March 4, 2005

By Jennifer Boggs

Allos Secures $50M Investment For Efaproxyn Phase III Program

March 4, 2005

By Jennifer Boggs

Osel Gains Lead Bacteria-Based Product Through Licensing Deal

March 3, 2005

By Jennifer Boggs

Osel Gains Lead Bacteria-Based Product Through Licensing Deal

March 3, 2005

By Jennifer Boggs

Discovery Acquires Biofrontera, Expects To Lose Money In 2005

March 2, 2005

By Jennifer Boggs

Discovery Acquires Biofrontera, Expects To Lose Money In 2005

March 2, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...